Mannkind (MNKD) Capital Expenditures Growth (3y) (2013 - 2026)
Mannkind (MNKD) Capital Expenditures Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Mannkind |
1.21 Bn |
1.08 Bn |
82.66 Mn |
-52.16% |
| Date | Value |
|---|
| Mar 31, 2026 |
-52.16% |
| Dec 31, 2025 |
-26.69% |
| Sep 30, 2025 |
7.62% |
| Jun 30, 2025 |
33.78% |
| Mar 31, 2025 |
-59.74% |
| Dec 31, 2024 |
53.79% |
| Sep 30, 2024 |
-40.35% |
| Jun 30, 2024 |
161.77% |
| Mar 31, 2024 |
19.54% |
| Dec 31, 2023 |
-53.37% |
| Sep 30, 2023 |
-1,683.65% |
| Jun 30, 2023 |
339.44% |
| Mar 31, 2023 |
323.93% |
| Dec 31, 2022 |
37.62% |
| Sep 30, 2022 |
-10.36% |
| Jun 30, 2022 |
-95.22% |
| Mar 31, 2022 |
165.88% |
| Mar 31, 2019 |
-38.28% |
| Mar 31, 2016 |
-7.79% |
| Dec 31, 2015 |
69.40% |
